找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy; Rajni A. Sethi,Igor J. Barani,Mack Roach, III Boo

[复制链接]
楼主: 人工合成
发表于 2025-3-28 17:02:42 | 显示全部楼层
发表于 2025-3-28 22:13:02 | 显示全部楼层
发表于 2025-3-28 23:56:51 | 显示全部楼层
发表于 2025-3-29 03:35:38 | 显示全部楼层
https://doi.org/10.1007/978-3-7091-5323-9nd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.
发表于 2025-3-29 10:06:52 | 显示全部楼层
发表于 2025-3-29 12:17:32 | 显示全部楼层
发表于 2025-3-29 16:21:30 | 显示全部楼层
Spine, early data suggest that stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Dose limiting toxicities and treatment precision are ongoing areas of controversy and investigation.
发表于 2025-3-29 21:20:21 | 显示全部楼层
Lungnd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.
发表于 2025-3-30 01:38:47 | 显示全部楼层
Digestive System organs, dose limiting toxicity remains the primary impediment to treatment, but advances in targeting and tracking precision have improved outcomes over recent years. Greater advances may be achieved in the coming years through the combination of stereotactic body radiotherapy with systemic chemotherapy or targeted molecular agents.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-10 06:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表